{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:45Z","timestamp":1791235305934,"version":"4.1.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"4","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,27]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Thrombosis is an important manifestation of the antiphospholipid syndrome (APS). The thrombin generation (TG) test is a global hemostasis assay, and increased TG is associated with thrombosis. APS is currently diagnosed based on clinical and laboratory criteria, the latter defined as anti-cardiolipin, anti\u2013\u03b22-glycoprotein I antibodies, or lupus anticoagulant (LA). APS testing is often performed after a thrombotic episode and subsequent administration of anticoagulation, which might hamper the interpretation of clotting assays used for LA testing. We set out to develop an artificial neural network (NN) that can diagnose APS in patients who underwent vitamin K antagonist (VKA) treatment, based on TG test results. Five NNs were trained to diagnose APS in 48 VKA-treated patients with APS and 64 VKA-treated controls, using TG and thrombin dynamics parameters as inputs. The 2 best-performing NNs were selected (accuracy, 96%; sensitivity, 96%-98%; and specificity, 95%-97%) and further validated in an independent cohort of VKA-anticoagulated patients with APS (n\u00a0= 33) and controls (n\u00a0= 62). Independent clinical validation favored 1 of the 2 selected NNs, with a sensitivity of 88% and a specificity of 94% for the diagnosis of APS. In\u00a0conclusion, the combined use of TG and NN methodology allowed for us to develop an NN that diagnoses APS with an accuracy of 92% in individuals with VKA anticoagulation (n\u00a0=\u00a095). After further clinical validation, the NN could serve as a screening and diagnostic tool for patients with thrombosis, especially because there is no need to interrupt anticoagulant therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011938","type":"journal-article","created":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T18:07:26Z","timestamp":1704132446000},"page":"936-946","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["A thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulation"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-0338","authenticated-orcid":false,"given":"Romy M. W.","family":"de Laat-Kremers","sequence":"first","affiliation":[{"name":"1Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Wahl","sequence":"additional","affiliation":[{"name":"2Vascular Medicine Division, French National Reference Center for Systemic Autoimmune and Autoinflammatory Disorders (Lupus Erythematosus, Antiphospholipid Antibody Syndrome), CHRU de Nancy, Universit\u00e9 de Lorraine, INSERM, D\u00e9faillance Cardio-Vasculaire Aig\u00fce et Chronique, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Zuily","sequence":"additional","affiliation":[{"name":"2Vascular Medicine Division, French National Reference Center for Systemic Autoimmune and Autoinflammatory Disorders (Lupus Erythematosus, Antiphospholipid Antibody Syndrome), CHRU de Nancy, Universit\u00e9 de Lorraine, INSERM, D\u00e9faillance Cardio-Vasculaire Aig\u00fce et Chronique, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Ninivaggi","sequence":"additional","affiliation":[{"name":"3Department of Functional Coagulation, Synapse Research Institute, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Regnault","sequence":"additional","affiliation":[{"name":"2Vascular Medicine Division, French National Reference Center for Systemic Autoimmune and Autoinflammatory Disorders (Lupus Erythematosus, Antiphospholipid Antibody Syndrome), CHRU de Nancy, Universit\u00e9 de Lorraine, INSERM, D\u00e9faillance Cardio-Vasculaire Aig\u00fce et Chronique, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Musial","sequence":"additional","affiliation":[{"name":"42nd Department of Internal Medicine, Jagiellonian University Medical College, Jagiellonian University, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"de Groot","sequence":"additional","affiliation":[{"name":"3Department of Functional Coagulation, Synapse Research Institute, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7559-2579","authenticated-orcid":false,"given":"Katrien M. J.","family":"Devreese","sequence":"additional","affiliation":[{"name":"5Coagulation Laboratory, Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium"},{"name":"6Department of Diagnostic Sciences, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9596-1944","authenticated-orcid":false,"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[{"name":"1Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, The Netherlands"},{"name":"3Department of Functional Coagulation, Synapse Research Institute, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"8","key":"2024022615310199100_bib1","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2024022615310199100_bib2","first-page":"668","article-title":"Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease","volume":"27","author":"Palomo","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2024022615310199100_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2024022615310199100_bib4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2024022615310199100_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jth.14682","article-title":"Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: a multicenter multiplatform study","volume":"18","author":"Yin","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024022615310199100_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/s-0039-1679901","article-title":"Detection of anti-cardiolipin and anti-beta2glycoprotein I antibodies differs between platforms without influence on association with clinical symptoms","volume":"119","author":"Chayoua","year":"2019","journal-title":"Thromb Haemost"},{"issue":"3","key":"2024022615310199100_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ijlh.12234","article-title":"Antiphospholipid antibody testing and standardization","volume":"36","author":"Devreese","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"2024022615310199100_bib8","doi-asserted-by":"crossref","first-page":"e71402","DOI":"10.1371\/journal.pone.0071402","article-title":"Variability in exposure of epitope G40-R43 of domain I in commercial anti-beta2-glycoprotein I IgG ELISAs","volume":"8","author":"Pelkmans","year":"2013","journal-title":"pLoS One"},{"issue":"4","key":"2024022615310199100_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0032-1311990","article-title":"Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part I \u2014anticardiolipin and anti-beta2-glycoprotein I antibodies","volume":"38","author":"Favaloro","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"2024022615310199100_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.thromres.2021.05.008","article-title":"Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence","volume":"203","author":"de Laat-Kremers","year":"2021","journal-title":"Thromb Res"},{"issue":"5","key":"2024022615310199100_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.blre.2012.06.001","article-title":"Thrombin generation: what have we learned?","volume":"26","author":"Al Dieri","year":"2012","journal-title":"Blood Rev"},{"key":"2024022615310199100_bib12","doi-asserted-by":"crossref","first-page":"1075121","DOI":"10.3389\/fcvm.2023.1075121","article-title":"Application of the thrombin generation assay in patients with antiphospholipid syndrome: a systematic review of the literature","volume":"10","author":"Gehlen","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"2024022615310199100_bib13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/bloodadvances.2018018036","article-title":"Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin","volume":"2","author":"Kremers","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"2024022615310199100_bib14","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/j.1538-7836.2007.02734.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants","volume":"5","author":"Liest\u00f8l","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"2024022615310199100_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0961203312440059","article-title":"Thrombin generation in antiphospholipid syndrome","volume":"21","author":"Zuily","year":"2012","journal-title":"Lupus"},{"issue":"1","key":"2024022615310199100_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1160\/TH08-06-0393","article-title":"Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography","volume":"101","author":"Devreese","year":"2009","journal-title":"Thromb Haemost"},{"issue":"4","key":"2024022615310199100_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1182\/blood-2009-09-244426","article-title":"Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants","volume":"115","author":"Devreese","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2024022615310199100_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jth.12798","article-title":"The balance of pro- and anticoagulant processes underlying thrombin generation","volume":"13","author":"Kremers","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2024022615310199100_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2017.06.011","article-title":"Neuroscience-inspired artificial intelligence","volume":"95","author":"Hassabis","year":"2017","journal-title":"Neuron"},{"issue":"5","key":"2024022615310199100_bib20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jvsv.2021.01.020","article-title":"Clinical guidelines versus current clinical practice for the management of deep vein thrombosis","volume":"9","author":"Rognoni","year":"2021","journal-title":"J\u00a0Vasc Surg Venous Lymphat Disord"},{"key":"2024022615310199100_bib21","doi-asserted-by":"crossref","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"issue":"7","key":"2024022615310199100_bib22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2024022615310199100_bib23","first-page":"2164","article-title":"Laboratory diagnosis of antiphospholipid syndrome: insights and hindrances","volume":"11","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"11","key":"2024022615310199100_bib24","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024022615310199100_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jth.12537","article-title":"Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH","volume":"12","author":"Devreese","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"2024022615310199100_bib25","doi-asserted-by":"crossref","first-page":"1759720x20910855","DOI":"10.1177\/1759720X20910855","article-title":"An update on the management of antiphospholipid syndrome","volume":"12","author":"Rodziewicz","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"10","key":"2024022615310199100_bib26","doi-asserted-by":"crossref","first-page":"e0164076","DOI":"10.1371\/journal.pone.0164076","article-title":"Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF Registry","volume":"11","author":"Haas","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"2024022615310199100_bib28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2024022615310199100_bib29","first-page":"575","article-title":"Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determination\u2014-a cooperative project of the European Antiphospholipid Forum","volume":"86","author":"Tincani","year":"2001","journal-title":"Thromb Haemost"},{"issue":"7","key":"2024022615310199100_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1538-7836.2010.03857.x","article-title":"Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome","volume":"8","author":"De Moerloose","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024022615310199100_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"4","key":"2024022615310199100_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"2024022615310199100_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.thromres.2018.07.011","article-title":"Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): a personal perspective","volume":"169","author":"Pengo","year":"2018","journal-title":"Thromb Res"},{"issue":"1","key":"2024022615310199100_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rdc.2022.08.001","article-title":"Venous thromboembolism in the inflammatory rheumatic diseases","volume":"49","author":"Misra","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"2024022615310199100_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2022.10.007","article-title":"Thrombin generation assay as a biomarker of cardiovascular outcomes and mortality: a narrative review","volume":"220","author":"Ferreira","year":"2022","journal-title":"Thromb Res"},{"issue":"6","key":"2024022615310199100_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2141.2007.06738.x","article-title":"Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence","volume":"138","author":"van Hylckama Vlieg","year":"2007","journal-title":"Br J Haematol"},{"issue":"7","key":"2024022615310199100_bib37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2024022615310199100_bib38","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3324\/haematol.2019.221655","article-title":"Thrombin generation in cardiovascular disease and mortality\u2014- results from the Gutenberg Health Study","volume":"105","author":"van Paridon","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"2024022615310199100_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1538-7836.2007.02824.x","article-title":"Coagulation factors and the protein C system as determinants of thrombin generation in a normal population","volume":"6","author":"Dielis","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024022615310199100_bib40","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/4\/936\/2215167\/blooda_adv-2023-011938-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/4\/936\/2215167\/blooda_adv-2023-011938-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T15:31:24Z","timestamp":1708961484000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/4\/936\/506906\/A-thrombin-driven-neural-net-diagnoses-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011938","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}